CALGARY, Alberta--(BUSINESS WIRE)--Absorb Software, maker of Absorb Learning Management System (LMS) has successfully completed its AICPA System and Organization Controls (SOC) 2 Type 2 examination ...
WASHINGTON, DC — Patients who received the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) in the ABSORB-3 trial showed a primary outcome, counting only events occurring between the ...
WASHINGTON, DC—Two-year results from the ABSORB III study presented today at the American College of Cardiology 2017 Scientific Session show that the Absorb GT1 bioresorbable vascular scaffold (BVS, ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The Absorb bioresorbable scaffold demonstrated overall clinical outcomes comparable to those of the ...
AMSTERDAM, NL — Consistent with prior trials, the risk of scaffold thrombosis was significantly higher in patients receiving the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) than an ...